xspa - XSPA STOCK NEWS

XpresSpa Group, Inc. (Nasdaq: XSPA) announced the appointment of James Berry as Chief Financial Officer, effective December 14, 2020. His experience includes leadership roles in healthcare organizations, where he optimized revenue cycles and developed financial strategies. The company also promoted Scott Milford to Chief Operating Officer, recognizing his contributions as Chief People Officer. XpresSpa is focused on transitioning into healthcare and wellness services, leveraging Berry's expertise to enhance its operational capabilities and growth potential.

XpresSpa Group, Inc. (Nasdaq: XSPA) has appointed David Kohel as Chief Technology Officer, a pivotal new role to enhance its technology framework. Kohel brings 22 years of experience from leading companies like Nike and Kroger, focusing on innovation and customer-centric strategies. His appointment aims to support XpresSpa's vision of becoming a leader in global Travel Health and Wellness. The company is known for its spa services in airports and COVID-19 testing through its XpresCheck brand, with locations in major airports.

XpresSpa Group (Nasdaq: XSPA) has announced the launch of its XpresCheck COVID-19 testing facility at Phoenix Sky Harbor International Airport, which will open before the holiday travel season. This facility will convert a closed urgent care clinic into six testing rooms capable of administering over 400 tests daily, offering rapid molecular, PCR, and blood antibody tests. XpresCheck aims to provide reliable testing and enhance travel safety, with partnership support from the City of Phoenix, which will cover costs for uninsured residents through Federal CARES Act funding.

XpresSpa Group, Inc. (XSPA) is transforming into a travel health and wellness brand, focusing on health-focused travel and wellness services. The company now operates three XpresCheck Wellness Centers at major airports, with plans for expansion, including a new location at Phoenix Sky Harbor International Airport in late November. For Q3 2020, XSPA reported revenue of $201,000, down from $12.5 million in Q3 2019, primarily due to COVID-19 impacts. Despite lower patient volumes, recent weeks have seen significant increases, largely due to new rapid testing services.

XpresSpa Group, Inc. (Nasdaq: XSPA) announced that its subsidiary XpresCheck has been designated as a Trusted Testing Partner by the State of Hawaii. This designation allows travelers to bypass a mandatory 14-day quarantine by presenting negative COVID-19 test results from XpresCheck. Their rapid molecular and PCR tests, available at major airports including JFK and Newark, comply with Hawaii's testing requirements. CEO Doug Satzman expressed satisfaction with this partnership, highlighting potential for increased travel from the east coast as nonstop flights may be resuming soon.

XpresSpa Group is set to announce its third quarter 2020 financial results on November 16, 2020, after market close. Following the announcement, a conference call will take place at 5:00 PM ET. Investors are encouraged to listen via webcast due to limited call capacity.

XpresSpa operates 50 locations in 25 airports globally, offering spa services and COVID-19 testing through its XpresCheck brand. This strategic focus on health and wellness products positions the company in a growing market.

XpresSpa Group, Inc. (Nasdaq: XSPA) has launched its XpresCheck COVID-19 testing facility at Boston Logan International Airport as of October 28, 2020. Positioned in Terminal E, the modular site features seven testing rooms and can conduct over 400 tests daily, including rapid molecular, PCR, and antibody tests. The facility will serve airport employees and travelers, ensuring a HIPAA-compliant environment. CEO Doug Satzman emphasized plans for national expansion, with ongoing discussions for additional sites.

XpresSpa Group, Inc. (Nasdaq: XSPA) has expanded its XpresCheck™ services to include rapid tests for influenza, mononucleosis, and group A streptococcus, in addition to its COVID-19 offerings. The company also provides this season's flu vaccinations, targeting both general travelers and airport employees. CEO Doug Satzman stated that the pandemic has heightened awareness of health during travel. XpresCheck aims to leverage its resources and infrastructure to support public health and prepare for future COVID-19 vaccinations as they become available.

XpresSpa Group, Inc. (Nasdaq: XSPA) has initiated construction of an XpresCheck™ COVID-19 testing facility at Boston Logan International Airport, expected to be operational by November. This facility will add to their existing locations at JFK and Newark, featuring seven testing rooms with a capacity of over 400 tests daily, offering rapid molecular, PCR, and blood antibody tests. CEO Doug Satzman emphasizes the company's role in supporting air travel safety and expresses intentions for further expansion.